ATLANTA--(BUSINESS WIRE)--Professor Geoffrey Dobson, Chief Science Officer, Hibernation Therapeutics, has been asked to address NATO’s top medical advisors about his research with Adenocaine® technology that can potentially save lives in far forward locations on the battlefield. He has been invited by the NATO Allied Command Operations Medical Advisor to speak about “Emerging Research in Trauma Care” at Europe top defense organization’s Operations Medical Conference in Madrid later this month (March 28-31).
